This study presents a numerical simulation of cardiovascular response in the heart failure condition under the support of a Berlin Heart INCOR impeller pump-type ventricular assist device (VAD). The model is implemented using the CellML modelling language. To investigate the potential of using the Berlin Heart INCOR impeller pump to produce physiologically meaningful arterial pulse pressure within the various physiological constraints, a series of VAD-assisted cardiovascular cases are studied, in which the pulsation ratio and the phase shift of the VAD motion profile are systematically changed to observe the cardiovascular responses in each of the studied cases. An optimization process is proposed, including the introduction of a cost function to balance the importance of the characteristic cardiovascular variables. Based on this cost function it is found that a pulsation ratio of 0.35 combined with a phase shift of 2008 produces the optimal cardiovascular response, giving rise to a maximal arterial pulse pressure of 12.6 mm Hg without inducing regurgitant pump flow while keeping other characteristic cardiovascular variables within appropriate physiological ranges.
INTRODUCTION
Numerical simulation has been extensively applied to the study of cardiovascular dynamics in heart failure under support with a ventricular assist device (VAD), and this has greatly promoted the design and analysis of VADs to achieve optimized cardiovascular response. In terms of system-level cardiovascular dynamics, including the examination of perfusion efficiency under different VAD configurations, the most useful information has come from zero-dimensional, lumped-parameter studies. Three-dimensional computational fluid dynamics has its role in the detailed analysis of flow fields in the device itself, for example to evaluate blood damage and thrombosis potential, and in the future will be applied in models of the heart and vasculature to evaluate details of physiological flow fields under left VAD support (http://www.euheart.eu).
Currently two types of VAD design are widely used in the treatment of end-stage heart failure: impeller pumps and displacement pumps. Compared with displacement pumps, impeller pumps have the advantages of compactness, no valves, a simpler control aspect, lower power consumption and lower relative cost [1] . However, most impeller-type VADs are designed to work in a constant speed mode, and thus, in principle, produce non-pulsatile flow. It is widely recognized that pulsatile flow has an important effect on circulation physiology: it promotes kidney and liver perfusion, and promotes microcirculation at the cell level, which is important in the early treatment of acute heart failure [2, 3] . In the heart failure condition under impeller pump support, the diseased myocardium has some remaining contractility, which can produce residual pulsatility in the blood flow, but such pulsatility is often negligible and does not have a physiological significance comparable to that of the healthy condition or of the condition of heart failure assisted with displacement pumps [3] . To enjoy the advantages of compact device design in the impeller pump VADs and the improved perfusion to peripheral organs with pulsatile blood flow, it has been proposed that the rotating speed of the impeller pump might be varied over the heart cycle [4 -7] . Several researchers have reported arterial pressure pulsation covering the physiological range of 80-120 mm Hg without thrombus formation. Qian [6] proposed the use of twisted impeller vanes to reduce the Reynolds shear stress, *Author for correspondence (d.r.hose@sheffield.ac.uk).
One contribution of 17 to a Theme Issue 'The virtual physiological human '. minimizing the haemolysis within the pump, and thus claimed to have produced the first effective pulsatile centrifugal blood pump. Gobel et al. [5] designed the Medos DeltaStream impeller pump and tested it under a sinusoidal speed variation of 3000-9500 r.p.m. The pump produced a pressure fluctuation between 80 and 120 mm Hg with no thrombus formation in testing. Vandenberghe et al. [8] compared the unloading effect of the Medos microdiagonal rotary blood pump under both continuous and pulsatile modes, and also studied the haemodynamic modes of ventricular assist with the Medos DeltaStream rotary blood pump in continuous and pulsatile modes [7] . In studies of VAD control strategy design, Giridharan & Skliar [9] and Ohuchi et al. [10] modulated the speed of the rotary blood pump and produced pulsation of arterial pressure covering the physiological range. However, Shi et al. [11] carried out numerical evaluations in a HeartMate III impeller pump and warned that, although modulating the pump rotating speed could produce physiological pressure pulsation, this control mechanism also induced strong regurgitant pump flow, which greatly reduced the pump efficiency. Since the cardiovascular response under VAD support depends on the interaction between the native circulation system and the VAD, and different VAD designs have different characteristics, more case studies are necessary, and it is imperative to test other impeller pumps under similar situations before a concrete conclusion can be drawn.
To evaluate the performance of VAD support and the effect of VAD interaction with the native cardiovascular system, it is necessary to determine which quantitative physiological criteria-including cardiac output, pressures in various parts of the circulation system, the balance of blood distribution between the systemic and the pulmonary circulation loops, the metabolic requirements of peripheral organs, the perfusion pressure of vital organs (such as brain and kidney) and VAD energy consumption-should be used to compare cardiovascular response under different VAD control strategies. Inevitably those strategies that produce optimal performance against one of the physiological criteria offer degraded performance against others. In the majority of publications to date, the focus has been on a subset of physiological criteria, neglecting the others; for example, cardiac outpute was the major concern in studies [4, [12] [13] [14] [15] [16] [17] ; left atrial pressure was the main target of VAD motion optimization in studies [13, 16, [18] [19] [20] ; left ventricular pressure was addressed in [21] ; arterial pressure in studies [13, [21] [22] [23] [24] ; pressure difference across the VAD in Wu et al. [24] and Waters et al. [25] ; peripheral vascular resistance in Abe et al. [12] and Saito et al. [16] ; heart oxygen consumption in Drzewiecki et al. [26] ; and venous oxygen saturation in Nakamura et al. [27] . Also some VAD characteristic variables such as VAD pump flow [23, 28] and VAD pump rotations per minute [10, 13] have been included in evaluating the VAD support performance. Although each of these publications offers valuable insight into specific aspects of performance, it is apparent that there is a need for an overall physiological indicator (a cost function) that shows the extent to which the balance between the conflicting performance requirements is met. Wu et al. [24] used a weighted average of aortic pressure and pressure difference across the VAD in the design of a VAD controller. He et al. [13] designed specific member functions to calculate the effects of individual physiological variables, including stroke volume, mean left atrial pressure, minimum aortic pressure and mean pump rotation speed, under different VAD motion conditions, and then computed the weighted average of these member functions to decide the overall quality of the VAD-assisted cardiovascular response. Such a weighted average of physiological variables provides a better solution to address the contradictory requirements in the optimization of VAD-assisted cardiovascular response. In this paper, we introduce a more comprehensive physiological indicator cost function. The numerical model described in Shi et al. [11] is used to study the cardiovascular response in a heart failure condition under the support of a Berlin Heart INCOR impeller pump, and to optimize a simple control algorithm against the proposed cost function.
Another difficulty that is faced when evaluating and integrating published results from different modelling groups is that rarely are the ranges of operation or the model implementations directly comparable. Traditionally, the cardiovascular models have been implemented anew by each research group using mainstream programming languages such as Fortran, C and Matlab. There is a recognized need to agree on a standard and uniform modelling specification to minimize the error due to algorithm and implementation differences and to make models portable to enable reproduction and extension of published data. In recent years, a new Extensible Markup Language (XML), CellML (Cell Markup Language) (http://www.cellml.org), has been developed at the Auckland Bioengineering Institute, University of New Zealand, in order to facilitate storing and exchange of computer-based mathematical models in a machine-and program-independent manner. CellML also enables components of one model to be used in another, thus accelerating the model-building process. Complementing the CellML language specification there is an integrated development environment, OpenCell (http://www.cellml.org/tools/opencell), to support CellML modelling. OpenCell provides the various functionalities of model construction, editing, validation, executing and results display. OpenCell offers the user a choice of several integration schemes for the solution of ordinary differential equations, including backwards Euler, Adams -Moulton and a two-stage implicit Runge -Kutta scheme. The simulation results can be displayed in OpenCell, or exported in comma-separated variable format for external post-processing. In the interests of transparency and portability, the CellML implementation of the model on which this paper is based has been made publicly available from the CellML model repository. Figure 1 shows a schematic of the whole system, based on that described by Shi et al. [11] . The system comprises two parts: the native cardiovascular system and the impeller pump. The inlet conduit of the impeller pump Haemodynamics under Impeller VAD Support Y. Shi et al. 321 is connected to the left ventricular apex to achieve improved unloading of the diseased ventricle. The outlet conduit of the pump is connected to the ascending aorta in order to minimize blood stasis in the aortic root.
MATERIAL AND METHODS

Numerical model of the system
A detailed zero-dimensional model of the native cardiovascular system has been described in Shi & Korakianitis [29] . The system is modelled in three main parts: the heart, the systemic circulation loop and the pulmonary circulation loop. The heart is modelled as a four-chamber pump with variable elastance and four heart valves that control the direction of blood flow. The systemic and pulmonary circulation loops are separated into aortic sinus/pulmonary artery sinus, arterial, arteriolar, capillary and venous compartments. The local resistance to blood flow, elasticity of blood vessels and inertia of blood are modelled in each compartment. The combined effect of venules, veins and venae cavae is modelled as the venous compartment. The arterial compartment represents the general characteristics of the aorta and the main and smaller arteries. The aortic sinus compartment characterizes the aortic root. The heart valve dynamics have also been modelled by combining pressure difference, frictional force and vortex effect on the valve leaflets.
The characteristics of the device are described by a relationship of the form Dp ¼ p(Q, v), based on the experimentally measured pressure-flow characteristic in the Berlin Heart INCOR impeller pump. Figure 2 shows the conceptual drawing of the pump characteristics for the Berlin Heart INCOR impeller pump.
CellML implementation
The numerical model for the whole system is represented using CellML v. 1.1 [30, 31] . This latest version of CellML supports the features of Import and Encapsulate, which enables modular assembly of model components. To take advantage of the modular structure, several template components are first defined: namely, TempRLC, TempRC, TempR, TempCDv, TempCDa, TempVAD, EAtrium and EVentricle. The first three provide lumped parameter representations of the governing equations for pressure and flow in the vessel segments and VAD cannula. TempCDv and Figure 3 lists the CellML description of the heart, and figure 4 describes the systemic loop. The pulmonary loop has a similar structure.
Strategy for the optimization of pump motion
The primary variable of pump operation that can be controlled is its rotation speed. Although most commonly used in a constant speed mode, it is possible to vary the speed over the cardiac cycle. In this paper, we explore the optimization of a two-parameter control algorithm, defined by the pulsation ratio (the amplitude of an imposed sinusoidal motion as a proportion of the necessary underlying constant component) and the phase of this imposed pulsation relative to the impaired contraction of the failing native heart. The control algorithm is described by the following equation:
The constant component of the VAD speed, v 0 , determines the cardiac output in a heart cycle. In this study, v 0 is chosen to produce a cardiac output of about 70 ml per beat and an arterial pressure of 80-120 mm Hg under the simulated typical vascular impedance. The two control variables of pulsation ratio (defined as the ratio of pulsatile to constant Figure 2 . Conceptual drawing of the pump characteristics for the Berlin Heart INCOR impeller pump. Table 1 . Nomenclature. components in the pump speed, v p /v 0 ) and phase shift f can be varied individually in the corresponding ranges to obtain the optimal cardiac support. In this study, the pulsation ratio is varied over a range 0 -1, in increments of 0.05. The upper limit of the pulsation ratio is chosen to avoid excessive regurgitant flow in the pump, which might happen at low VAD flows. The phase difference f is changed over the range 0 -3608, in increments of 108. Each combination of pulsation ratio and phase difference is examined to evaluate the cardiovascular performance. Figure 5 shows a typical temporal profile for the rotation speed of the impeller pump: the change of left ventricular elastance, E lv , is also indicated to illustrate the phase relation between the pump motion and the native ventricular contraction.
Evaluation of cardiovascular performance
As discussed above, many studies have focused on one or two specific cardiovascular performance measures. He et al. [13] introduced the notion of a cost function, balancing competing and conflicting requirements to describe an overall performance index. In this study, we introduce a new and more comprehensive cost function that includes a wider range of requirements (He et al. included four parameters, while this paper extends to eight). Like He et al., we define individual member functions that indicate the optimality of each individual performance parameter (such as cardiac output or left ventricular pressure). These individual contributors are multiplied to serve as the cost function that describes the overall performance of the system: the multiplication operation corresponds to the 'and' relation among the cardiovascular variables-overall cardiovascular response should ideally satisfy all of these variable constraints. It is suggested that there is a significant merit in the development of a single quantitative physiological performance index. While subjectivity remains in the determination of both the member functions and the cost function, the optimization process is formalized and clarified and it might be possible to achieve a community consensus on these basic building blocks. Not all parameters have the same degree of importance and constraints on their inter-relations, and this should be reflected in their member functions. An acceptable cardiovascular response requires that the cardiac output, the left atrial/ventricular pressure and the arterial pressure all lie within the normal ranges concurrently, while stroke volume and left ventricular volume are expected to lie outside the normal range but not by too much. One of the questions in the current study was whether a physiologically meaningful arterial pressure pulsation could be produced without causing regurgitant pump flow. Thus, the member functions are classified into two groups: a vital group and a non-vital group. The vital parameters should be maintained within the target ranges, within which their member functions are assigned a value of unity, and outside these ranges their member functions drop rapidly to zero, firstly to penalize and ultimately to exclude inappropriate modes of operation. For non-vital variables, the maximum value of the membership function remains at unity but the minimum value is assigned a positive value even if the parameter lies outside the target ranges, so that these terms have less impact on the final overall performance index (table 2). The final performance index is expressed as
ð2:2Þ
The definitions of the ranges and the forms of the functions are, of course, based on subjective judgement based on our knowledge and experience. Cardiac output should meet the normal requirement of 70 ml s 21 in order to provide sufficient perfusion to the organs. Further increase in cardiac output might be advantageous to the cardiovascular response, but it is not necessary when not physiologically needed. The pump flow is mainly decided by the pump rotating speed applied as the external control variable and the pressure difference across the pump. However, negative pump flow is often associated with impaired perfusion efficiency and increased blood cell damage and should be avoided. The VAD-assisted left ventricular pressure should be maintained in the range 5 -55 mm Hg. A smaller left ventricular pressure helps to pressureunload the heart and thus facilitates the recovery of the myocardium, while too low ventricular pressure will induce collapsing of the ventricular wall and needs to be avoided. The left atrial pressure preferably should be kept in the range 5 -10 mm Hg, achieving a balance between minimizing the potential of pulmonary oedema and not causing atrial suction and thus stopping of flow to the VAD. The arterial pressure should be maintained in the normal range of 80-120 mm Hg and should have the necessary pulsatility to minimize the vascular resistance and promote organ perfusion. Pulsatility of blood flow can be evaluated by the energy equivalent arterial pressure (defined as
Qdt, which is a measure of the pulsatile energy delivered by the heart and/or VAD) [32] and the arterial pulse pressure (i.e. the difference between the systolic and diastolic arterial pressures during a cardiac cycle, Dp ¼ P es 2 P ed ) [33] . The left ventricular volume should be decreased from the dilated condition to the normal range to volume-unload the heart chambers, and finally the stroke volume (approximately equals the volume difference of the left ventricle in a heart cycle) of the ventricle should be maximized within a reasonable range, in order to stimulate reverse remodelling of the diseased heart [34] . It should be noted that the stroke volume may not necessarily be equal to the cardiac output per heart cycle when the failing heart is supported with an impeller pump, owing to the continuous flow nature of the pump. Some other physiological requirements proposed or used by previous researchers, such as the balance of blood distribution between the systemic and the pulmonary circulation loops, metabolic requirement of peripheral organs, the perfusion pressure of vital organs, VAD energy consumption, heart oxygen consumption and venous oxygen saturation, are too complex or difficult to evaluate, and they are not considered in the current study. Based on these considerations, a number of member functions are constructed [35] , with each corresponding to the individual physiological variables assessed. They are listed in table 2.
System parameters
The values of the haemodynamic variables in the native cardiovascular model are the same as those used previously [29, 36] . Coefficients for the Berlin Heart INCOR pump model and parameters for the inlet and outlet cannulae are provided by Berlin Heart Gmbh. The heart period is set as 1 s (corresponding to 60 b.p.m.). The chosen numerical solution procedure employed a variable time step, determined by the characteristics of the solution itself.
Procedure of numerical study
First the CellML implementation of the numerical model is executed in the OpenCell environment to simulate the cardiovascular response in the healthy condition, to establish the basis of comparison with further cases. Then, the left ventricular systolic elastance is reduced to one-fifth of the normal value to simulate a typical heart failure condition. The regulatory effects of the sympathetic and parasympathetic nerves are not modelled, to facilitate direct comparison with the VAD-assisted system. The CellML simulation results were validated against the previously developed C implementation of the numerical model, and the two models gave consistent results. Figure 6 illustrates a snapshot of the computer screen for the CellML simulation session. Next in the numerical model the pump assistance is enabled, the pulsation ratio and the phase difference in the pump motion profile are both set to zero, and the cardiovascular response for different pump speeds is examined to find the baseline constant pump speed that can produce a normal cardiac output. This value is then used as the constant component of the VAD speed, and the pulsation ratio and the phase difference are changed in increments over their full ranges to simulate the cardiovascular response under different combinations of these two control parameters. Of course it would be possible to run an optimization routine directly to find the optimal solution of the cost function, but this would not characterize the solution space. For each case, the pressure, flow and volume changes are saved as Microsoft Excel CSV format data files. The CSV files are then read into Matlab, the converged cardiac cycles identified, and the characteristic physiological variables extracted, including cardiac output, maximum and healthy condition. These results agree well with typical cardiovascular responses [37] , and with all pressure, flow rate and volume parameters within the normal ranges. Figure 7b illustrates the simulation results in a typical left ventricular failure condition. Generally, the response curves have the same shapes as in the healthy condition but with altered variable values, corresponding to the impaired perfusion and the dilated left ventricular chamber in the heart failure condition. The cardiovascular response in the heart failure condition with the Berlin Heart INCOR support under baseline pump motion mode is shown in figure 7c . Here, a mean VAD flow rate of 78 ml s 21 is chosen as the standard situation against which all other cases are compared. Generally, the arterial pressure is restored to the normal range, and the ventricle is both pressureunloaded and volume-unloaded from the heart failure condition to the healthy level in figure 7a .
These simulation results also agree with previous validated data under the same conditions, as reported in Shi et al. [11] . These serve as the validation of the currently developed CellML model.
Searching for ventricular assist device
motion to produce satisfactory cardiovascular response including arterial pressure pulsation
Following the procedure introduced in §2.6, different parameter combinations for the phase difference f and pulsation ratio v p /v 0 are applied in the VAD motion profile to simulate the assisted cardiovascular dynamics, and the corresponding response is evaluated using the membership functions and performance index developed. Table 3 illustrates the changes in characteristic cardiovascular variables as well as the index values of each of the corresponding membership functions under the different f and v p /v 0 combinations. In table 3, the cardiac output changes in the range 70-80 ml for the different cases. Although there is a small improvement in cardiac output at a value of around 1208, generally f is not an important determinant of cardiac output. This is due to the counter pulsation effect; a higher pump speed in early diastole instead of in systole delays the development of an arterial pressure peak until diastole. Also, with the remaining contractility in the diseased left ventricle, the peak in the left ventricular pressure occurs in mid-systole. Thus a f value of 1208 helps to produce a slightly higher pressure difference across the VAD in systole, which contributes to the slightly elevated pump flow and accordingly to the overall improved cardiac output in the case with a f value of 1208. Note that the duration of systole is less than half of the heart period, as shown in figure 5 , and diastole starts at a phase of about 1208 from the start of heart contraction, instead of 1808. Variation in pulsation ratio has a more prominent effect than the phase difference on the cardiac output. It is observed that, when either the minimum value of 0 or the maximum value of 1 is assigned to v p /v 0 , the cardiac output will reach almost 78 ml, while between these two extreme conditions the cardiac output has a minimum, located at a v p /v 0 of about 0.55. Shi et al. [11] , analysing a different pump, reported a similar decrease in cardiac output over the interval to 0.55, but did not see the recovery at the higher pulsation ratios. This recovery is attributable to the different slope in the pump characteristic curves, as illustrated in figure 8a-c. As shown in figure 8a, the pump P-Q curve in the second quadrant of the P-Q plane, i.e. the regurgitant pump flow region, has a much steeper slope than that in the first quadrant, i.e. the normal forward pump flow region. Also, in the first quadrant, the P-Q curves have a steeper slope in the high flow range than in the low flow range. For a fixed pressure difference across the pump, suppose the constant pump rotating speed corresponds to the working point A, and the modulated maximum and minimum pump speeds v 0 + v p during a heart cycle correspond to the pump working points of B and C individually, then the corresponding changes in pump flow owing to pump speed modulation are DQ AB and DQ AC . As the pulsation ratio increases points B and C move to points B 0 and C 0 . A constant pump flow of Q A will produce a cardiac output of CO ¼ Q A T, with T being the heart period, whereas, with the pump speed modulation, the cardiac output is
DQ AB and DQ AC are individually illustrated as shaded areas in figure 8b. From the P-Q curves in figure 8a , it is observed that, as the pulsation ratio changes, flows Q A , Q B and Q C and flow difference DQ AB 2 DQ AC generally follow the trend as shown in figure 8c owing to the different slopes of the curves in different regions. The flow difference DQ AB 2 DQ AC is zero at the zero pulsation ratio. When the pulsation ratio increases, at first the relatively bigger slope in the P -Q curves between the flow range corresponding to points A and B compared with that corresponding to between points A and C produces a much smaller DQ AB than DQ AC , thus DQ AB 2 DQ AC , 0, and the overall cardiac output falls rapidly as the pulsation ratio increases. When the pulsation ratio increases further, point C moves to C 0 , which is in a much steeper area of the P-Q curves, so that the difference between DQ AB and DQ AC begins to decrease, although DQ AB is still less than DQ AC . When the pulsation ratio approaches 0.8, the difference between DQ AB and DQ AC becomes negligible and the drop in the cardiac output decreases to zero. Thus, overall the cardiac output exhibits the form illustrated in table 3. In summary, although the modulation of both amplitude ratio and phase produces changes in cardiac output, this parameter remains within the desired range over the whole of the operating space and so the membership function assumes a value of unity throughout.
The next two parameters investigated were the energy equivalent arterial pressure and the mean arterial pressure. In the low-frequency range, both of these parameters are approximately proportional to the cardiac output. The energy equivalent arterial pressure is in the range 95 -106 mm Hg. The index value for the energy equivalent arterial pressure is slightly smaller than 1 when v p /v 0 is in the range 0.3 -0.8 but, as illustrated in table 3, it is not significantly below its optimal range. Similar conclusions apply to the mean arterial pressure (not shown in table 3).
Generally, there is an inverse relationship between cardiac output and peak left atrial pressure; slightly more blood is accumulated in the left atrium when the cardiac output is low (v p /v 0 in the range 0.3 -0.9) and thus the peak left atrial pressure is higher. The model indicates that the left atrial pressure generally lies in the target range 5 -10 mm Hg and its contribution to the cost function remains close to unity, with a small drop off associated with a minor elevation in pressure over some of the solution space.
A single membership function for ventricular pressure is suggested, penalizing excessively high or excessively low pressure at any point in the cardiac cycle. The maximum left ventricular pressure is of direct clinical interest because it is closely related to the peak stress level of the cardiac muscle. The minimum left ventricular pressure is also of interest during VAD support, because when it is too low there is a strong potential for collapse of the ventricular wall. This will adversely affect normal VAD function in the same manner as atrial suction. Generally, the peak left ventricular pressure lies around the target level of 25 mm Hg over the v p /v 0 and f ranges, except in two regions. The first corresponds to the situation of counter pulsation in VAD assistance, for which 0.35 , v p /v 0 1 and 608 , f , 2108, and the peak left ventricular pressure is as high as 40 mm Hg. The second is related to the co-pulsation mode of VAD assistance, for which 0.7 , v p /v 0 1 and 2508 , f , 3608, and the peak left ventricular pressure is about 12 mm Hg. The minimum left ventricular pressure is also of interest during VAD support, because when it is too low there is a strong potential for collapse of the ventricular wall, which will adversely affect normal VAD function in the same manner as in the atrial suction. In terms of minimum left ventricular pressure, the acceptable region is confined to about 0.2 , v p /v 0 1 and 608 , f , 2708, as shown in the performance index plot for the membership function of the left ventricular pressure. The overall conclusion is that ventricular pressures are acceptable over most of the possible control spectrum. The unacceptable region is due to excessively low minimum left ventricular pressure (less than 5 mm Hg), which may induce ventricular wall suction during VAD support.
Arterial pulse pressure increases almost linearly from 1 to 32 mm Hg when the pulsation ratio increases from 0 to 1. In this range, the pulsation ratio v p /v 0 needs to be kept above 0.4 in order to produce the target minimum pressure pulsation of 15 mm Hg [33] . The phase shift has little influence on the arterial pressure pulsation, with only a small decrease in arterial pulse pressure when the phase shift is about 1208. Based on the form of the chosen membership function, the contribution of the arterial pressure pulse to the performance index exhibits a sharp change at the pulsation ratio of 0.4: below 0.4, the index value is 0.4, and above 0.4 it is 1.
In terms of pump flow, the critical issue is to avoid the development of regurgitant flow, which enormously decreases the pump efficiency and should be avoided. The plot for the minimum pump flow shows that the minimum pump flow exhibits a trend of a rapid drop from about 75 to 0 ml s
21
, when v p /v 0 increases from 0 to 0.4; for further increases in v p /v 0 , the minimum pump flow demonstrates a much slower drop, and the value decreases from 0 to about 253 ml s 21 . Also the minimum pump flow does not seem to be sensitive to the phase shift, with only a minor elevation near the region of 2008 for the phase shift. The upper limit of the pump flow is never a problem. Thus, correspondingly, the performance index plot for the membership function of VAD flow shows a steep variation at about 0.4 for v p /v 0 .
The minimum ventricular volume computed under the envelope of our simulations remained within the normal range, and so this did not prove to be a critical parameter under the conditions studied. In contrast, the peak volume did move into an unacceptable range, implying ventricular dilation, and so contributed to the optimization under this envelope of operation. Under other conditions, for example if the rotation speed were set too high, the minimum volume might become a critical factor. The response surface for the peak left ventricular volume is similar in form to that of the peak left atrial pressure. The model suggests that in most situations the peak left ventricular volume is above the ideal maximum ventricular volume of 130 ml; thus the performance index for the membership function of the left ventricular volume shows a negative response. As we have classified the left ventricular volume as a less important physiological variable, its index value does not affect the overall performance index much. It should be noted that, although the VAD assistance cannot fully restore the ventricular volume to the healthy condition in the range of 20-130 ml, this is the best that can be achieved in the current VAD application situation. In the current study, the membership functions are all constructed based on the more stringent totally healthy condition, instead of being based on the looser condition of VAD application practice.
The control of volume change of the left ventricle during a heart cycle is not strictly required as a criterion in the evaluation of VAD-assisted cardiac response, but operation over a healthy range would be regarded as a positive feature. Generally, increasing the pulsation ratio helps to produce elevated volume change. Phase shift also has a strong influence on the left ventricular volume change. At a phase of about 1508, the volume change in a heart cycle is minimized, and at about 3308 it is maximized. The achievement of larger volume changes in the presence of a VAD is difficult, and, for most of the operational range, the stroke volume is too low to claim positive performance with respect to this parameter; in only two regions, one for 0.3 , v p /v 0 1 and 2708 , f , 3608 and the other for 0.3 , v p /v 0 1 and 08 , f , 508, does the ventricular volume change reach normal physiological levels.
The index values for the membership functions examined individually above are combined using equation (2.2) to calculate the overall performance index, and figure 9 shows the result as a function of the two control variables. It can be seen that the performance index is 0 over most of the control range, meaning that the requirements for the characteristic cardiovascular variables are not satisfied in one way or another. Only in a small region of 0.2 , v p /v 0 0.4 and 908 , f , 2708 does the performance index rise to above 0, and the maximum value is 0.3, indicating that the conflicting requirements have made it impossible to find an operational condition in which all parameters lie within their individual optimal ranges. The peak performance index corresponds to the studied case of v p /v 0 ¼ 0.35 and f ¼ 2008. Figure 10a -c shows the corresponding pressure, flow and volume changes in the studied case during one heart cycle. Generally, the cardiovascular response for this case is acceptable, with the cardiac output, left atrial and ventricular pressures, mean arterial pressure and VAD flow all in the normal healthy range. However, there are also deficiencies in the response. Firstly, the amplitude of arterial pressure pulsation observed in figure 10a is 12.6 mm Hg, which is slightly below the criterion of 15 mm Hg in order to be classified as physiologically meaningful. However, it is difficult to further increase the arterial pressure pulsation under all the constraints: increasing the pulsation ratio in VAD motion helps to produce elevated pulsation in arterial pressure, but note that the minimum pump flow is already near zero, as shown in figure 10b , and any increase in pulsation ratio will induce regurgitant pump flow. Also the left ventricular volume is still a bit higher than it should be in the healthy condition, and the left ventricular volume change is less than expected, meaning the ventricular muscle experiences little exercise and is less favourable when recovery of cardiac muscle is expected.
DISCUSSION
The modulation of the rotation speed of an impeller pump over the cardiac cycle to produce arterial pressure pulsation has been proposed for many years. A number of numerical simulations or experimental results have been published to advocate the applicability of this technique [4 -7,38,39] . However, results in the current study confirm those published earlier in the context of a different pump design [11] : both revealed the development of strong regurgitant flow in the impeller pump when the pulsation ratio in the VAD motion profile is raised to the levels that might produce near-healthy arterial pressure pulsation. Regurgitant flow in the pump has several side-effects: firstly, it greatly reduces the pump efficiency and thus increases the pump power consumption; secondly, the regurgitant pump flow enormously increases the level of the oscillatory shear index of blood flow in the VAD, which increases the potential for blood cell damage; thirdly, the regurgitant pump flow contributes to an unrealistically higher level of energy equivalent pressure owing to the accompanying repeated changes in direction of the blood flow in the VAD, although the majority of the energy is wasted on reversing the flow direction in the VAD, instead of being delivered for the perfusion of the end organs. For this reason, regurgitant pump flow needs to be vigorously avoided in VAD motion planning. In reviewing the previous work, the regurgitant pump flow can be easily identified in those published data. Although the VAD devices used were different in those previous studies, few of them seem to have overcome the problem.
In the current study, a formal optimization procedure was developed, and a series of membership functions corresponding to fundamental characteristic cardiovascular variables were constructed to achieve an accurate single evaluation criterion for VAD-assisted cardiovascular response. It remains to establish a community consensus on the appropriate ranges and forms of the membership functions. With our chosen functions, a systematic investigation was carried out to cover the possible combinations of pulsation ratio and phase shift in VAD motion. The formalized procedure that was developed has the potential to be applied in serious VAD performance evaluations and motion optimizations.
In the current research, the membership functions constructed to evaluate the characteristic cardiovascular variables are based on the idealized healthy condition, which is quite a stringent requirement for the cardiovascular response. In clinical practice with VAD support, it is always difficult to maintain every physiological variable within the idealized range. For example, in patients with heart failure, the impedance of the vascular network is often different from that in the healthy condition, and this poses great difficulty in keeping both the cardiac output and the arterial pressure exactly in the healthy ranges. Similarly, the ventricular volume and the stroke volume are difficult to maintain at the same time. Thus, it is impossible to satisfy these membership functions concurrently in order to produce an overall performance index of 1. It would be of real value to the community to establish a more realistic set of membership functions, constructed to suit the practically achievable ranges of characteristic variables under VAD assistance.
In evaluating the level of pressure pulsation, the current study mainly adopted the rule of 15 mm Hg arterial pulse pressure, as suggested by Undar et al. [33] . Undar et al. also proposed more stringent criteria in which not only the pulse pressure was specified, but also the first derivative of aortic pressure, ejection time, stroke volume and pulse rate were constrained in order to be qualified as a physiologically meaningful pulsatile flow [40] . Actually both of these rules are empirically based and, given the importance of this parameter in driving the optimization process, a more objective definition for the physiologically meaningful pulsatile flow needs to be established, based on more comprehensive data from clinical measurements of organ perfusion conditions and the laboratory observations of cell and molecular level pathophysiological changes.
Several aspects of the system characteristics affect the final cardiovascular response: the native cardiovascular system, the VAD performance and the VAD motion profile. The current study uses a sinusoidal change in pump rotation speed for the VAD motion profile, and the pulsation ratio and the phase shift are used as two parameters in VAD control optimization. It is possible to design more complex VAD motion profiles, such as a triangle, square wave or even more complex spline curves, and this may produce a somewhat different cardiovascular response. However, this will not change the nature of the study. For example, regurgitant pump flow will still develop when the pulsation ratio is high, and the cardiac output and the arterial pressure still cannot be maintained exactly in the healthy range owing to the change in vascular impedance in the diseased condition. As to the characteristics of the native cardiovascular system, owing to the enormous difference in patients' conditions, usually only a typical disease case is studied, and patient-specific study will be the task of a later stage when the numerical/experimental techniques have become fully matured. This may leave a gap in the quantitative difference when comparing results from different research groups, but this should not produce a qualitative difference. The same rule also applies to the difference in VAD performance of the numerous VAD products from different manufacturers. Of course, it is always important to investigate a wide range of VAD products before drawing the final conclusion.
For convenience of calculation and demonstration of the results, the current study uses a heart rate of 60 b.p.m., while in clinical situations patients often have a higher heart rate of 80-100 b.p.m. Strictly speaking, the vasculature has a slightly lower impedance in such a frequency range when compared with the 60 b.p.m. situation, so the afterload to the pump will decrease slightly. At the same time, the heart contractility generally remains about the same. Thus under the same pump speed variation pattern, the pump working points will shift to the higher flow region slightly (to the right in the pump pressureflow curves in figure 2) . As a consequence, the pump flow and thus the aortic flow will increase slightly, while the arterial pulse pressure will exhibit a minor reduction because of the different slopes in the highand low-flow regions of the pump pressure-flow characteristics. Generally, variation in the vascular impedance between the current assumed heart rate and the clinical patient's heart rate is very small and thus the difference in heart rate will not cause appreciable changes to the current simulation results. However, in some other situations, such as serious hypotension or hypertension, the vessel impedance will deviate substantially from the above simulated condition. In hypertension, the stiffer and contracted vessels contribute to a much higher vessel impedance and greater afterload to the heart. With the preload to the ventricle/VAD maintained at a similar level to that in the systems analysed ( preload is decided by the venous/atrial pressure), the pump working point will move towards the lower flow region (to the left in figure 2 ). This induces a reduced pump flow and possibly higher arterial pressure pulsation. In hypotension, the situation will be just the opposite. Under both of these conditions, the changes in impedance are sufficiently great to warrant the operation of the model to explore these envelopes, but this is beyond the scope of the current work.
Besides the formalization of the procedure for the optimization of VAD-assisted cardiovascular response, formalization of the numerical model for the cardiovascular system itself is another area of exploration. In this aspect, CellML provides a good candidate for uniform model representation, exchange and calculation. CellML and the accompanying development tool of OpenCell are both free and open source, which avoids the technical barriers of model sharing and re-using. The current research takes advantage of the benefits provided by CellML and OpenCell in the model development, and has achieved similar simulation accuracy to previous model implementations but with greatly reduced model development effort. Some initial examples of the current model have been uploaded to the CellML model repository for public access. With this study and many other models published in the CellML model repository, CellML has been validated as a robust, efficient and easy to use modelling language.
CONCLUSIONS
This study reports on the development and application of a two-parameter control algorithm in the evaluation of cardiovascular response in a heart failure condition under the support of the Berlin Heart INCOR impeller pump-type VAD. Implementation in CellML enormously reduces the model development effort as well as facilitates the re-use and exchange of models. A formal procedure has been developed based on the multiplication of a number of membership functions to provide a single physiological performance index (a cost function) to enable the optimization of the control parameters. A parameter combination of 0.35 for the pulsation ratio and 2008 for the phase shift in the VAD control produces the best cardiovascular response under our stated cost function. In particular, it produces a maximum arterial pulse pressure of 12.6 mm Hg without inducing regurgitant pump flow and while maintaining other characteristic cardiovascular variables within the corresponding physiological ranges. The membership functions themselves, and the way in which they are combined, are based on a subjective assessment of the appropriate physiological ranges and of the relative importance of each term. Although the ranges in the current paper are based on published literature where available, a community consensus remains to be established on the appropriate ranges and forms of the membership functions.
The focus of the current paper is on the proposition and demonstration of an approach to optimization, with its application illustrated at one heart rate. Before practical implementation, we would propose that a whole envelope of simulations should be performed under a range of physiological states. Although this paper focuses on optimization under a rather narrow physiological envelope, representative of a rest condition, the methods could be applied to the development of a much more sophisticated control algorithm, based on adaptation to continuous monitoring of parameters such as heart rate. This level of control could yield the greatest benefit to the patient, but will require developments in monitoring technology as well as in optimization and control.
